𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A placebo controlled trial of diazepam and oxprenolol for anxiety

✍ Scribed by G. D. Burrows; B. Davies; L. Fail; C. Poynton; H. Stevenson

Publisher
Springer
Year
1976
Tongue
English
Weight
235 KB
Volume
50
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis

Sixty-two patients with moderately severe anxiety symptoms were treated in a double bline 3-week trial with either oxprenolol, diazepam or placebo. The Hamilton Anxiety Scale and a Target symptom improvement score were the main measures of change used. All treatment groups significantly improved in the three weeks of the trial. However in the third week of treatment improvement was greater in the diazepam and oxprenolol groups. Observer preferences significantly favoured the diazepam group. The implications of the study were discussed.

πŸ“œ SIMILAR VOLUMES

Ritanserin in the treatment of generaliz
Ritanserin in the treatment of generalized anxiety disorders: A placebo-controlled trial
✍ E. A. Pangalila-Ratu Langi; A. A. I. Jansen πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 381 KB πŸ‘ 2 views

In a double-blind trial, 22 patients treated with 5 mg b.i.d. of the selective serotonin-S2 antagonist ritanserin for 4 weeks were compared with 26 patients treated with placebo for generalized anxiety disorder (DSM 111: 300.02). Symptoms were assessed using the Hamilton Anxiety Rating Scale (HARS)

A comparative trial of doxepin and diaze
A comparative trial of doxepin and diazepam in anxiety states
✍ G. N. Bianchi; J. Phillips πŸ“‚ Article πŸ“… 1972 πŸ› Springer 🌐 English βš– 508 KB

The effects of doxepin and diazepam upon anxiety states were studied in a double-blind controlled trial which involved 50 anxious neurotics. The drugs were prescribed for three weeks and there were no drop-outs. The mean dose of doxepin was 113 rag/day and of diazepam 21 mg/day. Ratings of anxiety

An algorithm for evaluating the ethics o
An algorithm for evaluating the ethics of a placebo-controlled trial
✍ Robert J. Amdur; C.J. Biddle πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 320 KB

## Abstract The purpose of this article is to clarify the decision points that are important to consider when evaluating the ethics of a placebo‐controlled trial. The ethical requirements for research involving human subjects are reviewed, and the rationale for and potential problems with concomita

Analysis of myopathy in a placebo-contro
Analysis of myopathy in a placebo-controlled zidovudine trial
✍ David M. Simpson; Peter Slasor; Urania Dafni; Joseph Berger; Margaret A. Fischl; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 2 views

## Methods Myopathy occurs in association with human immunodeficiency virus type 1 (HIV-1) infection, 2,8,17,19 and AIDS Clinical Trials Group (ACTG) Protocol 016 was designed to explore the safety and efficacy of ZDV as toxicity of the antiretroviral agent zidovudine (ZDV, AZT). 3,6,9,15 Retrospe

A multicenter randomized placebo-control
A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome
✍ Roger Kurlan; Giovanna Crespi; Barbara Coffey; Kirsten Mueller-Vahl; Stephen Kov πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 730 KB

Background: Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome. Methods: There was a multicenter randomized, placebo-controlled, double-blind clinical trial of pramipexole given for 6 weeks in 63 children and adolescents with Touret